论文部分内容阅读
我们对 142例中晚 (Ⅱ -Ⅳ )期肺癌患者 ,在 3Ｄ立体放疗和加温治疗过程中进行动态观察 ,认为免疫反应不仅能帮助分析治疗效果 ,而且对判断患者预后具有一定的临床价值 ,现报道如下。资料和方法一、资料 :共治疗 142例 (男 98,女 44 )中晚期肺癌患者 ,年龄 39～ 85岁 ,平均 6 0
We performed dynamic observations in 142 patients with stage II-IV lung cancer during the period of 3D stereotactic radiotherapy and heating. We believe that the immune response not only helps analyze the therapeutic effect, but also has clinical value in judging the prognosis of patients. The report is as follows. Data and Methods I. Data: 142 patients (male 98, female 44) with intermediate-advanced lung cancer treated at the age of 39 to 85 years with an average of 60